Eli Lilly Message Board - Msg: 32946697

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,042

-1.2%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	9/23/2020 12:59:26 PM
	of 642

Eli Lilly CEO: Speed and industry cooperation are aiding coronavirus treatment development “One of the reasons we published this data last week was so our competitors who also are developing neutralizing antibodies can learn from that study and adapt their own efforts so we all get more of these things sooner,” said Ricks, who has been Eli Lilly’s CEO and chairman since 2017. A spirit of cooperation also explains why Eli Lilly teamed up with Amgen in a deal announced Thursday, according to Ricks, who described manufacturing as a “huge problem.” He added, “One drawback of neutralizing antibodies is while they may be pretty safe and they have good effects, they’re very hard to make.” More at: cnbc.com o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next